(Q58389005)
Statements
Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST (English)
0 references
September 2007
0 references
21
0 references
14
0 references
1977-1980
0 references